We are live on ! Find out more
AH

Andreas Halvorsen Viking Global Investors

AUM $35.1B
1-Year Est. Return 21.36%
 

Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.

This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+21.36%
3 Year Est. Return
+97.07%
5 Year Est. Return
+98.11%
10 Year Est. Return
+504%
AUM
$23.5B
AUM Growth
+$825M
Cap. Flow
+$352M
Cap. Flow %
1.49%
Top 10 Hldgs %
54.93%
Holding
76
New
13
Increased
23
Reduced
16
Closed
21

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$785M
2
TMUS icon
T-Mobile US
TMUS
+$463M
3
MA icon
Mastercard
MA
+$428M
4
APC
Anadarko Petroleum
APC
+$352M
5
MSFT icon
Microsoft
MSFT
+$293M

Sector Composition

Rank Sector Weight
1 Communication Services 23.31%
2 Healthcare 21.56%
3 Consumer Discretionary 15.15%
4 Energy 14.21%
5 Technology 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDVN
76
DELISTED
MEDIVATION, INC.
MDVN
-707,319
Closed -$32.5M

Similar funds

Andreas Halvorsen's Q2 2016 Portfolio in Review

As of Q2 2016, Andreas Halvorsen held 76 positions worth $23.5B, up 3.6% from $22.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Andreas Halvorsen's Q2 2016 filing shows 13 new, 23 increased, 16 reduced and 21 closed positions. Its largest new stake was Microsoft: 5,633,782 shares worth $288M. The largest sale was Allergan plc, an estimated $678M.

By sector, the portfolio is most concentrated in Communication Services at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Andreas Halvorsen's largest Q2 2016 buy was Microsoft: 5,633,782 shares worth $288M.
  • Andreas Halvorsen added most to Biogen in Q2 2016, an estimated $785M increase.
  • Andreas Halvorsen's biggest Q2 2016 reduction was Allergan plc, cutting an estimated $678M.
  • Andreas Halvorsen fully exited Elevance Health in Q2 2016, selling an estimated $674M.
  • Andreas Halvorsen's ten largest holdings make up 55% of its $23.5B portfolio in Q2 2016.
  • Andreas Halvorsen opened 13 new positions and closed 21 in Q2 2016.
  • Andreas Halvorsen's portfolio value rose 3.6% quarter-over-quarter to $23.5B.

Based on Viking Global Investors's 13F filing for Q2 2016, filed 15 Aug 2016.